PENTAX MEDICAL'S TRIPLE AIM IMPROVE CLINICAL OUTCOMES MAXIMISE VALUE ENHANCE EXPERIENCE AND SATISFACTION

Serial Number 97438316
605

Registration Progress

Application Filed
Jun 1, 2022
Under Examination
Approved for Publication
Jul 18, 2023
Published for Opposition
Jul 18, 2023
Registered

Trademark Image

PENTAX MEDICAL'S TRIPLE AIM IMPROVE CLINICAL OUTCOMES MAXIMISE VALUE ENHANCE EXPERIENCE AND SATISFACTION

Basic Information

Serial Number
97438316
Filing Date
June 1, 2022
Published for Opposition
July 18, 2023
Abandonment Date
August 4, 2023
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
605
Status Date
Aug 4, 2023

Rights Holder

Hoya Corporation

03
Address
6-10-1 Nishi-Shinjuku, Shinjuku-ku
Tokyo 160-8347
JP

Ownership History

Hoya Corporation

Original Applicant
03
Tokyo JP

Hoya Corporation

Owner at Publication
03
Tokyo JP

Legal Representation

Attorney
Michelle L. Mehok

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Aug 4, 2023 ABN5 O ABANDONMENT - AFTER PUBLICATION Loading...
Aug 4, 2023 MAB5 E ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION Loading...
Aug 2, 2023 EXAR I TEAS EXPRESS ABANDONMENT RECEIVED Loading...
Jul 26, 2023 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jul 18, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 18, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 28, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 13, 2023 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 6, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 6, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 6, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 6, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 6, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 1, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 1, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 30, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 25, 2023 EPEN O COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY Loading...
May 25, 2023 GEAP O EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
May 25, 2023 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
May 25, 2023 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Apr 24, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 24, 2023 ALIE A ASSIGNED TO LIE Loading...
Apr 24, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 25, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 3, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 3, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 3, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 26, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 10, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 9, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 4, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Additional Information

Design Mark
The mark consists of the black stylized wording "PENTAX MEDICAL'S TRIPLE AIM" above three parallelograms forming a windmill shape. A red parallelogram containing a line to the left of the stylized wording "IMPROVE CLINICAL OUTCOMES" all above an image of the head and shoulders of a surgeon wearing a mask to the left of a small equal sided cross inside a circle, both enclosed in a circle. A dark grey parallelogram with a line to the left of the stylized wording "MAXIMISE VALUE" all above a hand drawing a point-to-point line graph all inside a circle. A light grey parallelogram containing a line to the left the stylized wording "ENHANCE EXPERIENCE AND SATISFACTION" to the left of a heart with a hand cupped above and another hand cupped below the heart all enclosed in a circle. The color white represents background and is not part of the mark.
Color Claim
The color(s) black, red, dark grey and light grey is/are claimed as a feature of the mark.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICAL'S" AND "IMPROVE CLINICAL OUTCOMES" AND "MAXIMISE VALUE" AND "ENHANCE EXPERIENCE AND SATISFACTION"